Shibahara Hiroaki, Shiraishi Yasuko, Hirano Yuki, Kasumi Hiroyuki, Koyama Koji, Suzuki Mitsuaki
Department of Obstetrics and Gynecology, School of Medicine, Jichi Medical University, Tochigi, Japan.
Am J Reprod Immunol. 2007 Feb;57(2):142-6. doi: 10.1111/j.1600-0897.2006.00457.x.
Sperm immobilizing antibodies often interfere with the penetration of sperm through the cervical mucus. However, the relationship between sperm immobilizing antibody titer and the result of the post-coital test (PCT) has not yet been clarified. The aim of this study was to investigate whether the 50% sperm immobilization unit (SI50) titer, a quantitative measure of sperm immobilizing antibody, in patients' sera was correlated with the result of PCT.
The sperm immobilization test (SIT) was performed for 2834 infertile women in two university hospitals. The SI50 titers were evaluated by quantitative SIT. In some cases with sperm immobilizing antibody, PCT was carried out before ovulation and assessed according to the criteria of World Health Organization (1992). Infertile couples with abnormal semen characteristics were excluded.
Seventy-four of 2834 women had sperm immobilizing antibodies in their sera, giving a positive rate of 2.6%. Twenty-four (77.4%) of 31 women with sperm immobilizing antibodies and 28 (20.4%) of 137 women without the antibody had abnormal PCT results. There was a significant difference between the two groups (P<0.0001). When patients with sperm immobilizing antibodies were divided into two groups according to the SI50 titers, the abnormal result of PCT was obtained in all 10 patients with high (>10) SI50 titers, while that was 14 (66.7%) in 21 patients with low (10) SI50 titers. There was a significant difference between the two groups (P=0.04).
The SI50 titer in the serum can predict inhibitory effects on sperm migration through cervical mucus in immunologically infertile women. Evaluation of the SI50 titers in patients' sera seems to be useful for decision-making in infertile women with sperm immobilizing antibodies regarding whether they have the possibility of conceiving by timed intercourse.
精子制动抗体常常会干扰精子穿透宫颈黏液。然而,精子制动抗体滴度与性交后试验(PCT)结果之间的关系尚未明确。本研究的目的是调查患者血清中精子制动抗体的定量指标——50%精子制动单位(SI50)滴度是否与PCT结果相关。
在两家大学医院对2834名不孕女性进行了精子制动试验(SIT)。通过定量SIT评估SI50滴度。在一些存在精子制动抗体的病例中,在排卵前进行PCT,并根据世界卫生组织(1992年)的标准进行评估。排除精液特征异常的不孕夫妇。
2834名女性中有74名血清中存在精子制动抗体,阳性率为2.6%。31名有精子制动抗体的女性中有24名(77.4%)以及137名无该抗体的女性中有28名(20.4%)PCT结果异常。两组之间存在显著差异(P<0.0001)。当将有精子制动抗体的患者根据SI50滴度分为两组时,10名SI50滴度高(>10)的患者PCT结果均异常,而21名SI50滴度低(≤10)的患者中有14名(66.7%)PCT结果异常。两组之间存在显著差异(P=0.04)。
血清中的SI50滴度可以预测免疫性不孕女性中精子通过宫颈黏液迁移的抑制作用。评估患者血清中的SI50滴度对于有精子制动抗体的不孕女性在是否有可能通过定时性交受孕方面的决策似乎是有用的。